MedPath

Efficacy of TF1, & TF2 in Adult Subjects with exercise induced acute musculoskeletal pai

Phase 2
Completed
Registration Number
CTRI/2023/07/055271
Lead Sponsor
Arjuna Natural Private Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Adult subject, Male or female between 18-65 years of age.

A score of 5 or above on the NRS.

Subjects having exercise induced acute musculoskeletal pain which occurred within 24 hours before presentation.

Willing to give voluntary informed consent.

Exclusion Criteria

Subject with acute muscle spasms who need parenteral therapy, surgery or hospital admission for management, painful uncomplicated acute soft tissue injury of the upper or lower extremity, including acute injuries of ligaments, tendons, or muscles. Subjects with Grade 2 & 3 sprain or strain or muscle cramps due to dehydration.

Pain originating from bone.

Subjects with known history of osteoarthritis and rheumatoid arthritis.

Subjects with open wounds infected skin or other conditions of broken skin, skin affected by infection with inflammations at the site of proposed action.

Use of any oral or topical analgesic, antipyretic, sedative or anti-inflammatory treatment, Use of any topical products, including topical medications, sunscreens, lotions, moisturizers, and cosmetic products at the site of pain within 1 week prior study or during the study.

Any kind of neuralgic pain, headache and/or chronic pain

Previous adverse reaction or known allergy to herbal, NSAID, steroids or any other severe food allergies.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath